BIOGEN INC. (BIIB) revenue & profit
BIOGEN INC. (BIIB): revenue $9.9B, net income $1.3B in 2025; latest quarter +3.4% year over year. From SEC filings.
$9.9BRevenue 2025
TickerBIIB (Nasdaq)
IndustryHealthcare · Biological Products, (No Diagnostic Substances)
Revenue 2025$9.9B
Net income 2025$1.3B
Net margin13.1%
Annual revenue growth+2.2%
Latest quarter (2026 Q2) · Revenue$2.7B
vs. same quarter last year+3.4%
Latest quarter · Net income$97.5M
Annual revenue & net income
| Year | Revenue | Net income | |
|---|---|---|---|
| 2022 | $10.2B | $3B | |
| 2023 | $9.8B | $1.2B | |
| 2024 | $9.7B | $1.6B | |
| 2025 | $9.9B | $1.3B |
ℹ️ Not investment advice. Calendar-year figures as tagged by the SEC; a company’s fiscal year may end in a different month.